Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report have?

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report has 179 citations in the OpenAlex counts ScholarIQ stores.

When was Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report published?

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report has 2019 year in the ScholarIQ index.

What is the open-access status of Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report?

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report has bronze oa status in the ScholarIQ index.

What is the DOI of Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report?

The DOI for Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report is on the source record.

What is the PMID of Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report?

The PMID for Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report is on the source record.

What is the OpenAlex record for Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report?

The OpenAlex for Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report is on the source record.